Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

920
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
920
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.1K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.1K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

859
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
859
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

2.0K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adolescent Concussion and Return-to-Learn.

Pediatric annals·2016
Same author

Food Allergies and Eczema.

Pediatric annals·2015
Same author

Formula frustrations.

Pediatric annals·2015
Same author

Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor.

Genes & development·2003

Related Experiment Video

Updated: Mar 30, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.9K

Treating Teen Depression in Primary Care.

Sabrina Santiago

    Pediatric Annals
    |November 21, 2015
    PubMed
    Summary

    This case study highlights a 17-year-old diagnosed with major depressive disorder who is a candidate for antidepressant medication. It suggests pediatricians should be comfortable prescribing first-line agents for adolescent depression.

    Area of Science:

    • Psychiatry
    • Pediatrics
    • Pharmacology

    Background:

    • Adolescent depression presents with symptoms like sleep difficulties, dysthymia, and anhedonia.
    • Major depressive disorder (MDD) is a common diagnosis in adolescents, often with a family history.
    • Adolescents with MDD may benefit from pharmacotherapy in addition to psychotherapy.

    Purpose of the Study:

    • To illustrate a case of adolescent major depressive disorder.
    • To discuss the role of pharmacotherapy in treating adolescent depression.
    • To encourage primary care pediatricians to consider prescribing first-line antidepressants for eligible adolescents.

    Main Methods:

    • A clinical case vignette of a 17-year-old male patient with unipolar major depressive disorder.
    • Review of diagnostic criteria for major depressive disorder in adolescents.

    More Related Videos

    Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
    04:22

    Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

    Published on: May 30, 2025

    1.3K
    Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
    10:54

    Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

    Published on: November 21, 2025

    816

    Related Experiment Videos

    Last Updated: Mar 30, 2026

    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
    04:29

    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

    Published on: January 7, 2019

    29.9K
    Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
    04:22

    Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

    Published on: May 30, 2025

    1.3K
    Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
    10:54

    Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

    Published on: November 21, 2025

    816
  • Discussion of pharmacotherapy as a treatment option.

    • Main Results:

    • The patient met diagnostic criteria for unipolar major depressive disorder.
    • He had classic symptoms and a strong family history of depression.
    • He was deemed a suitable candidate for antidepressant medication initiation.

    Conclusions:

    • Adolescents with major depressive disorder can be good candidates for antidepressant medication.
    • Primary care pediatricians should feel confident in prescribing first-line agents for adolescent depression.
    • Collaboration with child and adolescent psychiatry may be beneficial but should not replace primary care comfort with these medications.